US Stock MarketDetailed Quotes

GDS GDS Holdings

Watchlist

24.050
+0.870+3.75%

Close Jan 3 16:00 ET

24.000
-0.050-0.21%

Post 18:45 ET

4.68BMarket Cap-8.07P/E (TTM)

GDS Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GDS Holdings Q3 2024 Earnings Date

Currency：USDNov 19, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	425.05M	422.61M	-2.44M
Miss Est.	+23.19%	+22.49%	-0.57%
EPS	-0.15	-0.16	-<0.01
Miss Est.	+52.70%	+51.45%	-3.97%

Analyst Rating

Strong Buy

Dec 31, 2024

GDS Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.196B	--
--	2024/Q4	-- / 3.127B	--
Nov 19, 2024	2024/Q3	2.966B / 2.983B	--
Aug 21, 2024	2024/Q2	2.826B / 2.793B	--
May 22, 2024	2024/Q1	2.627B / 2.663B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.196B--

--2024/Q4-- / 3.127B--

Nov 19, 20242024/Q32.966B / 2.983B--

Aug 21, 20242024/Q22.826B / 2.793B--

May 22, 20242024/Q12.627B / 2.663B--

Unlock Free Earnings Estimates

Open Account

GDS Holdings Earnings Reports

6-K: Report of foreign private issuer (related to financial reporting)

Nov 19, 2024 07:31 ET

6-K: Report of foreign private issuer (related to financial reporting)

Oct 31, 2024 07:05 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 21, 2024 08:45 ET

6-K: Report of foreign private issuer (related to financial reporting)

Aug 21, 2024 08:30 ET

Trending US Stocks

Symbol Mini Chart % Chg

DexCom

DXCM

+3.27%

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data